SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home ▸ Executive Leadership ▸ Deepak Jain
Deepak oversees the finance, supply chain, legal, secretarial and plays an important role in driving strategy, improving profitability, identifying new opportunities, improving cash generation and enabling organizational growth.
Deepak was previously with Ather Energy, where he led the company to significant revenue growth over four years as the Chief Financial Officer. Prior to that he was the India CFO for First Advantage, and for Apple wherein he was part of the team which led to Apple’s expansion in the India market. He has also held leadership roles at Procter & Gamble, and started his career at Ernst & Young India.
Deepak has over 25 years of experience managing multi-location operations and transactional revenues. He has successfully led business growth strategies working in different industries and is skilled in process engineering, distribution modelling, sales finance, tax compliance, and finance controlling across various regions and organizational structures.
Deepak is a Chartered Accountant with a Bachelor of Commerce degree from Calcutta University.
© 2025. Syngene International Limited